|4Jul 5, 4:30 PM ET

AVEO PHARMACEUTICALS INC 4

4 · AVEO PHARMACEUTICALS INC · Filed Jul 5, 2017

Insider Transaction Report

Form 4
Period: 2017-07-03
Dallas Matthew D
VP, Finance
Transactions
  • Award

    Stock Option (right to buy)

    2017-07-03+500,000500,000 total
    Exercise: $2.22Exp: 2027-07-03Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest on June 1, 2018, and the remainder of this option shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Company.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION